Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Acquired Immunodeficiency Syndrome

Interventions

DRUG

Nevirapine

DRUG

Zidovudine

DRUG

3TC

Trial Locations (3)

Boehringer Ingelheim Investigational Site, Soweto

Boehringer Ingelheim Investigational Site, Parow

Boehringer Ingelheim Investigational Site, Capetown